This website uses cookies to enhance the user experience.
GL

Geir Lund1958

Shareholdings
3
7
Norway Business roles
26

Roles

Management

NameRoleTotal operating incomeTotal equityShares
V
VITAMAX AS
Managing Director/CEO
-
2,982,742
50 %
indirectly
L
LUNDS KLINIKK AS
Managing Director/CEO
1,021,852
114,160
50 %
directly
B
BIOPHARMA AS
Managing Director/CEO
28,277,574
5,851,092
40.32 %
indirectly
P
PHARMATECH AS
Managing Director/CEO
424,981,522
32,188,248
40.32 %
indirectly
B
BIOSAN AS
Managing Director/CEO
5,195,708
8,617,973
40.32 %
indirectly
G
GME LUND HOLDING AS
Managing Director/CEO
-
15,881,277
40.32 %
directly
M
MULTILAB ØSTFOLD AS
Managing Director/CEO
5,993,815
1,698,979
40.32 %
indirectly
F
FARMATEKET AS
Managing Director/CEO
150,213
462,090
40.32 %
indirectly
L
LUND EIENDOM FREDRIKSTAD AS
Managing Director/CEO
8,549,760
24,042,431
40.32 %
indirectly
Managing Director/CEO
-
-
-

Boards

NameRoleTotal operating incomeTotal equityShares
P
PHARMAPAC AS
Contact Person
-
29,368
50 %
directly
V
VITAMAX AS
Chairman
-
2,982,742
50 %
indirectly
L
LUNDS KLINIKK AS
Chairman
1,021,852
114,160
50 %
directly
B
BIOPHARMA AS
Chairman
28,277,574
5,851,092
40.32 %
indirectly
P
PHARMATECH AS
Chairman
424,981,522
32,188,248
40.32 %
indirectly
B
BIOSAN AS
Chairman
5,195,708
8,617,973
40.32 %
indirectly
G
GME LUND HOLDING AS
Board Member
-
15,881,277
40.32 %
directly
M
MULTILAB ØSTFOLD AS
Chairman
5,993,815
1,698,979
40.32 %
indirectly
F
FARMATEKET AS
Chairman
150,213
462,090
40.32 %
indirectly
L
LUND EIENDOM FREDRIKSTAD AS
Chairman
8,549,760
24,042,431
40.32 %
indirectly
Holder
-
-
-
B
BIO-SAN ANS
Contact Person
-
-
-
L
LAVENDULA ANS
Contact Person
-
-
-
Last update: Apr 13, 2023

Shares owned by Geir Lund

NameShare classTotal operating incomeTotal equityShare
L
LUNDS KLINIKK AS
Ordinære aksjer
1,021,852
114,160
50 %
directly
P
PHARMAPAC AS
Ordinære aksjer
0
29,368
50 %
directly
V
VITAMAX AS
0
2,982,742
50 %
indirectly
G
GME LUND HOLDING AS
Ordinære aksjer
0
15,881,277
40.32 %
directly
B
BIOPHARMA AS
28,277,574
5,851,092
40.32 %
indirectly
P
PHARMATECH AS
424,981,522
32,188,248
40.32 %
indirectly
B
BIOSAN AS
5,195,708
8,617,973
40.32 %
indirectly
M
MULTILAB ØSTFOLD AS
5,993,815
1,698,979
40.32 %
indirectly
F
FARMATEKET AS
150,213
462,090
40.32 %
indirectly
L
LUND EIENDOM FREDRIKSTAD AS
8,549,760
24,042,431
40.32 %
indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025